VLN · Valens Semiconductor Ltd.

$1.48 -0.05 (-3.27%) At close · Jul 29

Market Cap

$152.51M

103.05M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Insider Sentiment Score

Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.

Net buyers

-5

Net shares bought

-0.07%

Net buy value

-$212,125

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-07-23	Rozenberg Haine Yael	VP Finance	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sale reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2026 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.755. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	2,750	$1.73	$4,746	137,942
2026-07-22	Rozenberg Haine Yael	VP Finance	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sale reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2026 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.72. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	3,125	$1.71	$5,357	140,692
2026-07-20	Rozenberg Haine Yael	VP Finance	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sale reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2026	Ordinary Shares	1,458	$1.71	$2,493	143,817
2026-07-14	LICHTMAN MOSHE	Director	Sell↓ Filing footnotes — Ordinary Shares (Indirect) The shares sold represent shares withheld and sold by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted share units This Form 4 reports only the transaction effected by NGR Ltd. No transactions occurred with respect to other securities beneficially owned by the reporting person.	Ordinary Shares (I)	3,750	$2.01	$7,519	122,700
2026-07-14	Yaacobi Tal	Director	Sell↓ Filing footnotes — Ordinary Shares (Direct) The shares sold represent shares withheld and sold by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted share units	Ordinary Shares	3,750	$2.01	$7,519	68,498
2026-07-01	Yaacobi Tal	Director	Sell↓ Filing footnotes — Ordinary Shares (Direct) The shares sold represent shares withheld and sold by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted share units	Ordinary Shares	1,400	$2.22	$3,108	72,248
2026-06-15	Rozenberg Haine Yael	VP Finance	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2026 The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	17,374	$2.35	$40,777	145,275
2026-06-15	Chairman David	SVP R&D	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares sold were acquired upon the exercise of stock options on the same date The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	4,000	$2.43	$9,730	403,968
2026-06-15	Rozenberg Haine Yael	VP Finance	Convert↑ Filing footnotes — Ordinary Shares (Direct) The shares were acquired upon the exercise of stock options	Ordinary Shares	1,453	$0.86	$1,250	164,102
2026-06-15	Chairman David	SVP R&D	Convert↑ Filing footnotes — Ordinary Shares (Direct) The shares were acquired upon the exercise of stock options	Ordinary Shares	4,000	$0.86	$3,440	407,968
2026-06-15	Rozenberg Haine Yael	VP Finance	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	1,453	—	—	0
2026-06-15	Chairman David	SVP R&D	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	4,000	—	—	75,695
2026-06-15	Rozenberg Haine Yael	VP Finance	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2026 The shares sold were acquired upon the exercise of stock options on the same date	Ordinary Shares	1,453	$2.36	$3,429	162,649
2026-05-29	Boim Amir	SVP Operations and PMO	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	8,507	—	—	0
2026-05-29	Boim Amir	SVP Operations and PMO	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2025 The shares sold were acquired upon the exercise of stock options on the same date	Ordinary Shares	8,507	$3.55	$30,200	403,968
2026-05-29	Boim Amir	SVP Operations and PMO	Convert↑ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2025 The shares were acquired upon the exercise of stock options	Ordinary Shares	8,507	$0.86	$7,319	412,475
2026-05-29	Yarel - Toledano Adi	Director	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	17,225	—	—	22,325
2026-05-29	Yarel - Toledano Adi	Director	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025 The shares sold were acquired upon the exercise of stock options on the same date The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	17,225	$3.53	$60,859	164,253
2026-05-29	Yarel - Toledano Adi	Director	Convert↑ Filing footnotes — Ordinary Shares (Direct) The shares were acquired upon the exercise of stock options	Ordinary Shares	17,225	$2.39	$41,168	181,478
2026-05-28	Boim Amir	SVP Operations and PMO	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	1,431	—	—	8,507
2026-05-28	Yarel - Toledano Adi	Director	Convert↑ Filing footnotes — Ordinary Shares (Direct) The shares were acquired upon the exercise of stock options	Ordinary Shares	5,100	$2.39	$12,189	169,353
2026-05-28	Boim Amir	SVP Operations and PMO	Convert↑ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2025 The shares were acquired upon the exercise of stock options	Ordinary Shares	1,431	$0.86	$1,231	405,399
2026-05-28	Boim Amir	SVP Operations and PMO	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2025 The shares sold were acquired upon the exercise of stock options on the same date	Ordinary Shares	1,431	$3.50	$5,009	403,968
2026-05-28	Yarel - Toledano Adi	Director	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	5,100	—	—	39,550
2026-05-28	Yarel - Toledano Adi	Director	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025 The shares sold were acquired upon the exercise of stock options on the same date	Ordinary Shares	5,100	$3.50	$17,850	164,253
2026-05-13	Chairman David	SVP R&D	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	4,000	—	—	79,695
2026-05-13	Chairman David	SVP R&D	Convert↑ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares were acquired upon the exercise of stock options	Ordinary Shares	4,000	$0.86	$3,440	407,968
2026-05-13	Yarel - Toledano Adi	Director	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025 The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	19,179	$3.02	$57,967	164,253
2026-05-13	Chairman David	SVP R&D	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares sold were acquired upon the exercise of stock options on the same date The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	4,000	$2.98	$11,924	403,968
2026-05-12	Ben Zvi Gideon	Director	Other↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The reported transaction reflects the forfeiture of unvested stock options in connection with the reporting person's cessation of service as an officer of the Company. The securities were forfeited without consideration.	Stock Option (Right to Buy)	131,123	—	—	59,601
2026-05-12	Ben Zvi Gideon	Director	Other↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The reported transaction reflects the forfeiture of unvested stock options in connection with the reporting person's cessation of service as an officer of the Company. The securities were forfeited without consideration.	Stock Option (Right to Buy)	48,670	—	—	62,575
2026-05-12	Ben Zvi Gideon	Director	Other↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The reported transaction reflects the forfeiture of unvested stock options in connection with the reporting person's cessation of service as an officer of the Company. The securities were forfeited without consideration.	Stock Option (Right to Buy)	8,750	—	—	8,750
2026-05-12	Ben Zvi Gideon	Director	Other↓ Filing footnotes — Ordinary Shares (Direct) The reported transaction reflects the forfeiture of unvested restricted stock units in connection with the reporting person's change in role from officer to director. The securities were forfeited without consideration pursuant to the terms of the applicable award agreement.	Ordinary Shares	179,606	—	—	522,548
2026-05-12	Ben Zvi Gideon	Director	Other↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The reported transaction reflects the forfeiture of unvested stock options in connection with the reporting person's cessation of service as an officer of the Company. The securities were forfeited without consideration.	Stock Option (Right to Buy)	20,859	—	—	90,386
2026-05-08	Chairman David	SVP R&D	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	4,000	—	—	83,695
2026-05-08	Chairman David	SVP R&D	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares sold were acquired upon the exercise of stock options on the same date The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	4,000	$2.54	$10,172	403,968
2026-05-08	Chairman David	SVP R&D	Convert↑ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares were acquired upon the exercise of stock options	Ordinary Shares	4,000	$0.86	$3,440	407,968
2026-04-30	Yarel - Toledano Adi	Director	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025 The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	19,179	$2.06	$39,530	202,611
2026-04-30	Yarel - Toledano Adi	Director	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025 The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	19,179	$2.50	$47,971	183,432
2026-04-23	Chairman David	SVP R&D	Convert↑ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares were acquired upon the exercise of stock options	Ordinary Shares	3,600	$0.86	$3,096	407,568
2026-04-23	Chairman David	SVP R&D	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares sold were acquired upon the exercise of stock options on the same date The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	3,600	$1.67	$5,995	403,968
2026-04-23	Chairman David	SVP R&D	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	3,600	—	—	87,695
2026-04-22	Chairman David	SVP R&D	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	400	—	—	91,295
2026-04-22	Chairman David	SVP R&D	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares sold were acquired upon the exercise of stock options on the same date	Ordinary Shares	400	$1.65	$660	403,968
2026-04-22	Chairman David	SVP R&D	Convert↑ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares were acquired upon the exercise of stock options	Ordinary Shares	400	$0.86	$344	404,368
2026-04-16	Chairman David	SVP R&D	Convert↓ Filing footnotes — Stock Option (Right to Buy) (Direct) The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.	Stock Option (Right to Buy)	2,384	—	—	91,695
2026-04-16	Chairman David	SVP R&D	Convert↑ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares were acquired upon the exercise of stock options	Ordinary Shares	2,384	$0.86	$2,050	406,352
2026-04-16	LICHTMAN MOSHE	Director	Sell↓ Filing footnotes — Ordinary Shares (Indirect) The shares sold represent shares withheld and sold by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted share units This Form 4 reports only the transaction effected by NGR Ltd. No transactions occurred with respect to other securities beneficially owned by the reporting person.	Ordinary Shares (I)	3,750	$1.47	$5,513	126,450
2026-04-16	Yaacobi Tal	Director	Sell↓ Filing footnotes — Ordinary Shares (Direct) The shares sold represent shares withheld and sold by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted share units	Ordinary Shares	3,750	$1.47	$5,513	73,648
2026-04-16	Chairman David	SVP R&D	Sell↓ Filing footnotes — Ordinary Shares (Direct) The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares sold were acquired upon the exercise of stock options on the same date The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.	Ordinary Shares	2,384	$1.50	$3,588	403,968

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 56 transactions

Key facts CIK 1863006 CUSIP M9607U115 13F (30d) 7 filings 7 filers Visit website Investor relations